Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck

Anticancer Research

Volumn 34, Issue 1, 2014, Pages 243-248

  Mourad, Waleed F ^a   Kenneth, S H U ^a   Shasha, Daniel ^a   Concert, Catherine ^a   Ishihara, D A N ^a   Wilson, L I N ^a   Shourbaji, Rania A ^a   Ryniak, Magdalena ^a   Gamez, Mauricio E ^b   Lukens, John N ^a   Zujun, L I ^a   Culliney, Bruce E ^a   Khorsandi, Azita S ^a   Tran, Theresa ^a   Jacobson, Adam ^a   Manolidis, Spiros ^a   Schantz, Stimson ^a   Urken, Mark ^a   Persky, Mark S ^a   Harrison, Louis B ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b Department of Medical Oncology Beth Israel Medical Center ^*

Author keywords

Metastatic unknown primary cancer squamous cell carcinoma; Oropharynx targeted radiation therapy concurrent chemoradiotherapy

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CAUCASIAN; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONCURRENT CHEMORADIOTHERAPY; CONTROLLED STUDY; DYSPHAGIA; DYSPHONIA; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTATIC SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE DISTRIBUTION; RETROSPECTIVE STUDY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STIFF NECK; TASTE DISORDER; TRISMUS; XEROSTOMIA; AGED; CANCER STAGING; CLINICAL TRIAL; HEAD AND NECK TUMOR; METASTASIS; METASTATIC UNKNOWN PRIMARY CANCER SQUAMOUS CELL CARCINOMA; MIDDLE AGED; OROPHARYNX; OROPHARYNX-TARGETED RADIATION THERAPY CONCURRENT CHEMORADIOTHERAPY; PATHOLOGY; PROGNOSIS; RADIATION EXPOSURE; VERY ELDERLY; YOUNG ADULT;

METASTATIC UNKNOWN PRIMARY CANCER SQUAMOUS CELL CARCINOMA; OROPHARYNX-TARGETED RADIATION THERAPY CONCURRENT CHEMORADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; OROPHARYNX; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84897027825     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lefebvre JL, Coche-Dequeant B, Ton Van J, Buisset E and Adenis A: Cervical lymph nodes from an unknown primary tumor in 190 patients. The American journal of surgery 160(4):443-446, 1990.
2. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E and Jensen BB: Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology. Radiotherapy and Oncology 55(2): 121-129, 2000.
3. Pereira G, Silva JC and Monteiro E: Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study. Head & Neck Oncology 4(1): 1-7, 2012.
4. Erkal HŞ, Mendenhall WM, Amdur RJ, Villaret DB and Stringer SP: Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 50(1): 55-63, 2001.
5. Marcial-Vela VA, Cardenes H, Perez CA, Devineni VR, Simpson JR, Fredrickson JM, Sessions DG, Spector GG and Thawley SE: Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys 19, no. 4: 919-928, 1990.
6. Nieder C and Ang KK: Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol 3: 33-40, 2002.
7. Nieder C, Gregoire V and Ang KK: Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50: 727-733. 2001.
8. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ and Desanto LW: Cervical nodal metastasis of squamous cell carcinoma of unknown origin: Indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 23: 743-749. 1992.
9. Amdur RJ, Li JG, Liu C, Hinerman RW and Mendenhall WM: Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26: 257-263, 2004.
10. Barker CA, Morris CG and Mendenhall WM: Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site. Am J Clin Oncol 5: 445-448, 2005.
11. Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF and Forastiere AA: An intergroup phase III trial comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98, 2003.
12. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB and Fu KK: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350: 1937-1944, 2004.
13. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre, JL, Greiner RH and van Glabbeke M: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945-1952, 2004.
14. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J and Tadic L: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18: 1458-1464, 2000.
15. Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ and Vokes EE: Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 14: 1306-1311, 2003.
16. De Braud F, Heilbrun LK, Ahmed K, Sakr W, Ensley JF, Kish JA, Tapazoglou E and Al Sarraf M: Metastatic squamous cell carcinoma of an unknown primary localized to the neck: Advantages of an aggressive treatment. Cancer 64: 510-515. 1989.
17. Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q and Donald PJ: Radiation therapy in the management of head and neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Int J Radiat Oncol Biol Phys 81: 346-353, 2011.
18. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS and Garden AS: Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: MD Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 78: 1005-1010, 2010.
19. Klem ML, Mechalakos JG, Wolden SL, Zelefsky MJ, Singh B, Kraus D and Lee NY: Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 70: 1100-1107, 2008.
20. Lindel K, Beer KT, Laissue J, Greiner RH and Aebersold DM: Human papilloma virus positive squamous cell carcinoma of the oropharynx. Cancer 92(4): 805-813, 2001.
21. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA and Sidransky D: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. New England Journal of Medicine 332(11): 712-717, 1995.
22. Lo EJ, Bell D, Woo JS, Li G, Hanna EY and Sturgis EM: Human papillomavirus and WHO type I nasopharyngeal carcinoma. The Laryngoscope 120(10): 1990-1997, 2010.
23. Cox J, Stetz J and Pajak T: Toxicity criteria of the RTOG and the EORTC. Int J Radiat Oncol Biol Phys 30;31(5): 1341-1346, 1995.